|
ZNF615 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.77649999996999E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.60190000000993E-06 |
| Normal-vs-Stage2 |
2.03339999998997E-05 |
| Normal-vs-Stage3 |
1.08910000018447E-07 |
| Normal-vs-Stage4 |
3.10879999998459E-06 |
| Stage1-vs-Stage2 |
4.721000E-01 |
| Stage1-vs-Stage3 |
7.921600E-02 |
| Stage1-vs-Stage4 |
3.644600E-01 |
| Stage2-vs-Stage3 |
6.016200E-01 |
| Stage2-vs-Stage4 |
8.983800E-01 |
| Stage3-vs-Stage4 |
6.974800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.90170000033707E-07 |
| Normal-vs-AfricanAmerican |
4.844200E-03 |
| Normal-vs-Asian |
4.51430000003583E-06 |
| Caucasian-vs-AfricanAmerican |
5.291400E-01 |
| Caucasian-vs-Asian |
8.814000E-01 |
| AfricanAmerican-vs-Asian |
6.432400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85873999999364E-05 |
| Normal-vs-Female |
1.61230000017554E-07 |
| Male-vs-Female |
4.564300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.34899999954175E-07 |
| Normal-vs-Age(41-60Yrs) |
5.95209999953994E-07 |
| Normal-vs-Age(61-80Yrs) |
2.87899999951158E-07 |
| Normal-vs-Age(81-100Yrs) |
2.477900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.488000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.583810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.943800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.028000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.132400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.918600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.759900E-04 |
| Classical-VS-Follicular |
4.024200E-02 |
| Classical-VS-Other |
5.971000E-01 |
| Classical-VS-Normal |
2.46849999999688E-05 |
| Tall-VS-Follicular |
1.337630E-01 |
| Tall-VS-Other |
1.818980E-01 |
| Tall-VS-Normal |
1.36200000167008E-08 |
| Follicular-VS-Other |
2.679400E-01 |
| Follicular-VS-Normal |
6.04569999951288E-07 |
| Other-VS-Normal |
1.895040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.07610004135483E-09 |
| Normal-vs-N1 |
1.19409999999043E-07 |
| N0-vs-N1 |
3.235200E-01 |
|
|
